Related Experiment Video
Updated: May 10, 2026

Depletion and Reconstitution of Macrophages in Mice
Published on: August 1, 2012
Macrophage activation syndrome in a child affected by malaria: the choice of steroid
1Department of Health Sciences, University of Florence, Anna Meyer Childrens University Hospital, Florence, Italy.
Abstract:
Macrophage activation syndrome is a potentially fatal clinical syndrome caused by an excessive activation and proliferation of macrophages and T cells, leading to an exaggerated inflammatory reaction. It is well known that it can complicate the course of different conditions, especially autoimmune, lympho-proliferative, infectious diseases and drugs. Many infective pathogens can trigger the syndrome but the association with malaria has rarely been described, especially in children. We report a child with severe malaria complicated by MAS, in whom the clinical appearance of this syndrome could be considered as worsening of malaria itself. Furthermore, the use of steroids as first choice drugs in this complication, but arguable in malaria, has been highlighted. Clinicians should be aware of this syndrome when malaria does not respond to conventional therapy, since early diagnosis and prompt treatment may dramatically reduce the mortality associated with this condition.
Insights
Macrophage activation syndrome (MAS) is a rare but severe complication of malaria, particularly in children. Early recognition and treatment are crucial for reducing mortality in these cases.
Area of Science:
- Pediatrics
- Immunology
- Infectious Diseases
Background:
- Macrophage activation syndrome (MAS) is a life-threatening condition characterized by excessive immune cell activation.
- MAS can complicate various diseases, including infections, autoimmune disorders, and lymphoproliferative conditions.
- The association between MAS and malaria, especially in pediatric cases, is infrequently reported.
